Search Within

Saad Zafar Usmani

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (51)
  2. Journal Article (13)
  3. Research Letter (3)
  4. Correspondence (2)
Groups
  1. Biostatistics Service (69)
  2. Epidemiology and Biostatistics (69)
  3. Department of Medicine (68)
  4. Hematologic Malignancies, Division of (68)
  5. Center for Hematologic Malignancies (66)
  6. CTCR Scholars (64)

More Groups

People
  1. Alexander Lesokhin (62)
  2. Urvi Shah (62)
  3. Malin Hultcrantz (59)
  4. Sham Mailankody (58)
  5. Andriy Derkach (57)
  6. Carlyn Rose Tan (57)

More People

Years
  1. 2025 (2)
  2. 2024 (21)
  3. 2023 (28)
  4. 2022 (18)
Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (22)
  2. Blood (20)
  3. Journal of Clinical Oncology (10)
  4. Blood Cancer Journal (6)
  5. Blood Advances (3)
  6. American Journal of Hematology (1)

More Publications

Publishers
  1. American Society of Hematology (23)
  2. Elsevier Inc. (23)
  3. American Society of Clinical Oncology (10)
  4. Nature Publishing Group (7)
  5. American Association for Cancer Research (1)
  6. Ferrata Storti Foundation (1)

More Publishers

Results (69)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I trial of MCARH109, a first-in-class G Protein Coupled Receptor Class C Group 5 Member D (GPRC5D)-targeted CAR T-cell therapy for relapsed or refractory multiple myeloma: Updated analysis
    Meeting Abstract

    Jurgens, E.; Firestone, R.; Chaudhari, J.; Hosszu, K.; Devlin, S.; Shah, U.; Landa, J.; McAvoy, D.; Lesokhin, A.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Maintenance therapy cessation for multiple myeloma patients with three-year sustained mrd negative remissions
    Meeting Abstract

    Korde, N.; Hassoun, H.; Landau, H.; Hamid, S.; Derkach, A.; Hultcrantz, M.; Mailankody, S.; Tan, C.; Shah, U.; Maclachlan, K.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Artificial intelligence enabled interpretation of ECG images to predict hematopoietic cell transplantation toxicity
    Journal Article

    Shaffer, B. C.; Brown, S.; Chinapen, S.; Mangold, K. E.; Lahoud, O.; Lopez-Jimenez, F.; Schaffer, W.; Liu, J.; Giralt, S.; Devlin, S.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma
    Research Letter

    Hultcrantz, M.; Hassoun, H.; Korde, N.; MacLachlan, K.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C. R.; Chung, D. J.; Lahoud, O. B.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Diagnosis disclosure patterns among patients with plasma cell disorders
    Meeting Abstract

    Malik, M.; Dalvi, A.; Derkach, A.; Aldana, A. M. S. S.; Martinez, J. A. H.; Merlo, G.; Ahlstrom, J. M.; Hydren, J. R.; Usmani, S. Z.; Chimonas, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Supplement use habits and perceptions in patients with plasma cell disorders
    Meeting Abstract

    Leyfman, Y.; Schach, E.; Derkach, A.; Castro, F.; Martínez, J. A. H.; Aldana, A. M. S. S.; Pérez, P. A. F.; Malik, M.; Ahlstrom, J. M.; Hydren, J. R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Real-world schedule de-escalation of teclistamab in patients with relapsed/refractory multiple myeloma
    Meeting Abstract

    Tan, C. R. C.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Shah, G. L.; Scordo, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of retreatment with daratumumab-based regimens in anti-CD38 refractory multiple myeloma
    Meeting Abstract

    Tan, C. R. C.; Rueda, C.; Shekarkhand, T.; Derkach, A.; Korde, N.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
    Journal Article

    Nath, K.; Shekarkhand, T.; Nemirovsky, D.; Derkach, A.; Costa, B. A.; Nishimura, N.; Farzana, T.; Rueda, C.; Chung, D. J.; Landau, H. J.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma
    Journal Article

    Costa, B. A.; Flynn, J.; Nishimura, N.; Devlin, S. M.; Farzana, T.; Rajeeve, S.; Chung, D. J.; Landau, H. J.; Lahoud, O. B.; Scordo, M.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save